Under-30s to be offered alternative to AstraZeneca COVID-19 vaccine after reports of rare blood clots
People under 30 are to be offered alternatives to the Oxford/AstraZeneca COVID-19 vaccine after the MHRA said evidence was 'firming up' of a link between the vaccine and extremely rare blood clots.
